Cargando…

Different associations between organ-specific immune-related adverse event and survival in non-small cell lung cancer patients treated with programmed death-1 inhibitors-based combination therapy

BACKGROUND: The profile of immune-related adverse events (irAEs) due to programmed death-1 (PD-1) inhibitors-based combination therapy in advanced non-small cell lung cancer (NSCLC) and its relationship with survival have not been fully described. OBJECTIVE: Designed to capture the spectrum of irAEs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yuzhong, Shi, Yuanjian, Ding, Hanlin, Feng, Yipeng, Zhang, Te, Liang, Yingkuan, Wang, Hui, Song, Xuming, Chen, Bing, Xia, Wenjie, Mao, Qixing, Shen, Bo, Xu, Lin, Dong, Gaochao, Jiang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644755/ https://www.ncbi.nlm.nih.gov/pubmed/38028145 http://dx.doi.org/10.1177/17588359231210678

Ejemplares similares

Non-genetic stratification reveals epigenetic heterogeneity and identifies vulnerabilities of glycolysis addiction in lung adenocarcinoma subtype
por: Song, Xuming, et al.
Publicado: (2022)

circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression
por: Liang, Yingkuan, et al.
Publicado: (2020)

Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway
por: Zhang, Te, et al.
Publicado: (2022)

The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma
por: Feng, Yipeng, et al.
Publicado: (2023)

A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

The TWIST1-centered competing endogenous RNA network promotes proliferation, invasion, and migration of lung adenocarcinoma
por: Xia, Wenjie, et al.
Publicado: (2019)

Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy
por: Yin, Xuewen, et al.
Publicado: (2023)

Circular RNA circCRIM1 inhibits invasion and metastasis in lung adenocarcinoma through the microRNA (miR)‐182/miR‐93‐leukemia inhibitory factor receptor pathway
por: Wang, Lin, et al.
Publicado: (2019)

CircIMMP2L promotes esophageal squamous cell carcinoma malignant progression via CtBP1 nuclear retention dependent epigenetic modification
por: Liang, Yingkuan, et al.
Publicado: (2021)

Upregulated Collagen COL10A1 Remodels the Extracellular Matrix and Promotes Malignant Progression in Lung Adenocarcinoma
por: Liang, Yingkuan, et al.
Publicado: (2020)

Aberrant super-enhancer landscape reveals core transcriptional regulatory circuitry in lung adenocarcinoma
por: Zhang, Te, et al.
Publicado: (2020)

N (6)‐methyladenosine‐modified circFUT8 competitively interacts with YTHDF2 and miR‐186‐5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma
por: Dong, Gaochao, et al.
Publicado: (2023)

Effect of lymph node examined count on accurate staging and survival of resected esophageal cancer
por: Xia, Wenjie, et al.
Publicado: (2019)

Clinical and prognostic implications of an immune‐related risk model based on TP53 status in lung adenocarcinoma
por: Song, Xuming, et al.
Publicado: (2021)

Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma
por: Li, Rutao, et al.
Publicado: (2022)

Improvement of survival for non-small cell lung cancer over time
por: Xia, Wenjie, et al.
Publicado: (2017)

CT-Based Deep Learning Model for Invasiveness Classification and Micropapillary Pattern Prediction Within Lung Adenocarcinoma
por: Ding, Hanlin, et al.
Publicado: (2020)

Young age increases risk for lymph node positivity but decreases risk for non-small cell lung cancer death
por: Xia, Wenjie, et al.
Publicado: (2018)

Integrative analysis of differential genes and identification of a “2‐gene score” associated with survival in esophageal squamous cell carcinoma
por: Wang, Lin, et al.
Publicado: (2018)

A network-based signature to predict the survival of non-smoking lung adenocarcinoma
por: Mao, Qixing, et al.
Publicado: (2018)

CircCNTNAP3-TP53-positive feedback loop suppresses malignant progression of esophageal squamous cell carcinoma
por: Wang, Hui, et al.
Publicado: (2020)

Microarray analyses reveal genes related to progression and prognosis of esophageal squamous cell carcinoma
por: Qixing, Mao, et al.
Publicado: (2017)

Gut Microbiota Shapes the Efficiency of Cancer Therapy
por: Ma, Weidong, et al.
Publicado: (2019)

Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis
por: Qixing, Mao, et al.
Publicado: (2015)

PKM2 and cancer: The function of PKM2 beyond glycolysis
por: DONG, GAOCHAO, et al.
Publicado: (2016)

Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels
por: Dong, Gaochao, et al.
Publicado: (2016)

The Long Noncoding RNA LINC00665 Facilitates c-Myc Transcriptional Activity via the miR-195-5p MYCBP Axis to Promote Progression of Lung Adenocarcinoma
por: Wang, Anpeng, et al.
Publicado: (2021)

DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma
por: Xia, Wenjie, et al.
Publicado: (2015)

The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patients
por: Huang, Xing, et al.
Publicado: (2022)

SNP-Target Genes Interaction Perturbing the Cancer Risk in the Post-GWAS
por: Yang, Wenmin, et al.
Publicado: (2022)

Integrative analysis of copy number and transcriptional expression profiles in esophageal cancer to identify a novel driver gene for therapy
por: Dong, Gaochao, et al.
Publicado: (2017)

CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies
por: Mao, Qixing, et al.
Publicado: (2015)

Self-restricted circular RNA circSOX2 suppressed the malignant progression in SOX2-amplified LUSC
por: Liang, Yingkuan, et al.
Publicado: (2022)

Fatal adverse events associated with programmed cell death protein 1 or programmed cell death-ligand 1 monotherapy in cancer
por: Zhao, Bin, et al.
Publicado: (2020)

Hospital deaths and adverse events in Brazil
por: Martins, Mônica, et al.
Publicado: (2011)

Adverse cardiac events in the treatment of non-small cell lung cancer with programmed death-1and programmed death-ligand 1 inhibitors: A protocol for systematic review and meta-analysis
por: Li, Honglin, et al.
Publicado: (2020)

Immune-related adverse events induced by programmed death protein-1 inhibitors from the perspective of lymphoma immunotherapy
por: Hou, Yong-Zhe, et al.
Publicado: (2023)

Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis
por: Wang, Xuewen, et al.
Publicado: (2020)

Incidence of Immune-Related Adverse Events with Program Death Receptor-1- and Program Death Receptor-1 Ligand-Directed Therapies in Genitourinary Cancers
por: Maughan, Benjamin L., et al.
Publicado: (2017)

Characterization and Prognostic Significance of Cutaneous Adverse Events to Anti-Programmed Cell Death-1 Therapy
por: Lee, Ye Jin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jnko3u8c30t55f9kn950f8nuge